PagnatoKarp Partners’s GSK GSK Stock Holding History

PagnatoKarp Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,228	Closed	-$300K	–	54
2020 Q1	$300K	Sell	6,228 -285	-4%	-$15.2K	0.07%	125
2019 Q4	$387K	Hold	6,513	–	–	0.07%	137
2019 Q3	$351K	Sell	6,513 -175	-3%	-$9K	0.07%	139
2019 Q2	$338K	Buy	6,688 +781	+13%	+$39.2K	0.07%	138
2019 Q1	$313K	Buy	5,907 +329	+6%	+$16.4K	0.07%	131
2018 Q4	$270K	Sell	5,578 -720	-11%	-$35.5K	0.06%	122
2018 Q3	$320K	Sell	6,298 -5,625	-47%	-$286K	0.09%	125
2018 Q2	$608K	Sell	11,923 -3	-0%	-$151	0.19%	72
2018 Q1	$590K	Buy	11,926 +572	+5%	+$26.6K	0.25%	68
2017 Q4	$511K	Buy	11,354 +6,116	+117%	+$283K	0.16%	89
2017 Q3	$270K	Buy	5,238 +588	+13%	+$29.8K	0.09%	116
2017 Q2	$253K	Buy	4,650 +64	+1%	+$3.41K	0.08%	112
2017 Q1	$245K	Buy	+4,586	New	+$233K	0.07%	110

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return